Skip to main content

Table 4 Validation of the risk detection rate by the JAMRISC questionnaire for MetS, pre-MetS, type 2 diabetes, and pre-diabetes in 396 subjects that underwent blood testing

From: Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan

  1. aAmong the 396 subjects who underwent blood testing, 52 subjects (equivalent to 13.1 %) were diagnosed with MetS, among whom 49 (94.2 %) exhibited the risk scores of ≥20
  2. bHigh detection rates were also shown for pre-MetS, type 2 diabetes and pre-diabetes
Back to article page

Environmental Health and Preventive Medicine

ISSN: 1347-4715

Contact us